Streetbeat News

Products Services

STVN

SCHOTT Pharma, Gerresheimer, and Stevanato Group have formed an alliance to promote Ready-to-Use (RTU) vials and cartridges, aiming to enhance efficiency and reduce risks in pharmaceutical packaging. The alliance seeks to lower operational costs and improve product quality, while also creating an open platform for industry standards.

Portfolio Pulse from Benzinga Newsdesk

September 26, 2024 | 10:41 am

AREC

American Resources Corporation and LOHUM Cleantech have signed a Memorandum of Understanding with ReElement Technologies and American Metals to form a joint venture. This venture aims to establish the first fully integrated battery recycling, repurposing, and critical material production facility in the US, with a 15.5 GWh capacity and an initial investment of $30 million. The facility is expected to create 250 green jobs and supply over 315,000 electric vehicles annually.

Portfolio Pulse from Benzinga Newsdesk

September 26, 2024 | 10:39 am

NNVC

NanoViricides, Inc. has secured a right of first refusal for all antiviral drug developments from TheraCour Pharma, enhancing its ability to develop broad-spectrum antiviral drugs. The company plans to advance its lead drug, NV-387, to Phase II trials.

Portfolio Pulse from Benzinga Newsdesk

September 26, 2024 | 10:36 am

ENGN

enGene announced preliminary data from the LEGEND study of Detalimogene Voraplasmid (EG-70) in treating Bacillus Calmette-Guérin-unresponsive, non-muscle invasive bladder cancer with carcinoma in situ, showing a complete response rate of 71%.

Portfolio Pulse from Benzinga Newsdesk

September 26, 2024 | 10:34 am

CRTO

Criteo has partnered with Selfridges to offer brands premium spaces for connecting with luxury shoppers. This two-year partnership will enable sponsored products and personalized onsite displays on Selfridges' online properties.

Portfolio Pulse from Benzinga Newsdesk

September 26, 2024 | 10:29 am

CNTA

Centessa Pharmaceuticals has shared new preclinical data from non-human primate studies of ORX142, a treatment for excessive daytime sleepiness in certain neurological, neurodegenerative, and psychiatric disorders.

Portfolio Pulse from Benzinga Newsdesk

September 26, 2024 | 10:08 am

QH

Quhuo has launched a new booking platform through its homestay division, Chengtu Home, offering six functional room types. This development aims to enhance service capabilities and provide a wider range of high-quality accommodation options.

Portfolio Pulse from Benzinga Newsdesk

September 26, 2024 | 10:05 am

AXNX

The Australian Therapeutic Goods Administration has approved Axonics' R20 Rechargeable Sacral Neuromodulation System for marketing. Axonics plans to start sales in Australia in November, targeting overactive bladder and fecal incontinence treatments.

Portfolio Pulse from Benzinga Newsdesk

September 26, 2024 | 10:05 am

ENTA

Enanta Pharmaceuticals announced that its Phase 2A study of EDP-323 in healthy adults infected with RSV met primary and secondary endpoints, showing significant reductions in viral load and symptoms compared to placebo.

Portfolio Pulse from Benzinga Newsdesk

September 26, 2024 | 10:02 am

DDS

LVLU

Lulu's Fashion Lounge has entered a strategic collaboration with Dillard's to offer its latest collections in over 30 Dillard's stores nationwide. This partnership will focus on special occasion and event apparel, emphasizing style, quality, and attainable luxury.

Portfolio Pulse from Benzinga Newsdesk

September 26, 2024 | 10:01 am